Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and The Experimental Therapeutics Institute (ETI) at the Icahn School of Medicine at Mount Sinai today announced that they have …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced an agreement with theBiomedical Advanced Research and Development Authority (BARDA) of the U.S.
A number of Wall Street analysts weighed in on their favorite stocks this morning before market open. Below are the most notable analyst …
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that, in a new pooled analysis of heterozygous familial hypercholesterolemia (HeFH) patients included in …
In a research report released today, Chardan Capital analyst Gbola Amusa downgraded shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) from a Buy to a Hold raring, while …
Recently, various executives have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), GoPro Inc (NASDAQ:GPRO), Novavax, Inc.
On Tuesday, August 4, before market open, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported its second-quarter 2015 financial results that beat both top and bottom line expectations. The biotech giant, which recently …
In a research report issued today, J.P.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares increased 5.55% in pre-market trading to $585.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced financial results for the second quarter of 2015 and provided an update on development programs. “With the recent approval …
